Rigel Pharmaceuticals (RIGL) EBIT Margin Growth (3y) (2013 - 2026)
Rigel Pharmaceuticals (RIGL) EBIT Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - | - |
| 2 | Nanobiotix | 1,908.96 Bn | 1,908.90 Bn | - | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - | - |
| 4 | BeOne Medicines | 474.03 Bn | 469.24 Bn | 1.35 Bn | 9,942.00 |
| 5 | Vertex Pharmaceuticals | 122.13 Bn | 114.88 Bn | 2.59 Bn | 530.00 |
| 6 | Regeneron Pharmaceuticals | 70.09 Bn | 61.34 Bn | 3.31 Bn | -1,211.00 |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - | - |
| 8 | Argenx Se | 55.96 Bn | 50.77 Bn | 1.41 Bn | -623.00 |
| 9 | Alnylam Pharmaceuticals | 37.53 Bn | 34.52 Bn | 959.66 Mn | 6,993.00 |
| 10 | Rigel Pharmaceuticals | 701.13 Mn | 554.44 Mn | 54.21 Mn | 6,902.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,902.00 |
| Dec 31, 2025 | 2,914.00 |
| Sep 30, 2025 | 12,303.00 |
| Jun 30, 2025 | 10,357.00 |
| Mar 31, 2025 | 18,087.00 |
| Dec 31, 2024 | 13,386.00 |
| Sep 30, 2024 | 11,725.00 |
| Jun 30, 2024 | 5,089.00 |
| Mar 31, 2024 | -7,512.00 |
| Dec 31, 2023 | 10,754.00 |
| Sep 30, 2023 | 5,907.00 |
| Jun 30, 2023 | 8,897.00 |
| Mar 31, 2023 | -8,652.00 |
| Dec 31, 2022 | 11,663.00 |
| Sep 30, 2022 | -2,441.00 |
| Jun 30, 2022 | 16,157.00 |
| Mar 31, 2022 | -1,134.00 |
| Dec 31, 2021 | -11,163.00 |
| Sep 30, 2021 | 40,909.00 |
| Jun 30, 2021 | 141,149.00 |